CareTrust REIT, Inc. (CTRE) Stock Price & Analysis
CareTrust REIT, Inc. (CTRE) closed at USD 36.62 on Thursday, October 22, 2026, up 2.72% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 35.65; the Oct 22, 2026 session ranged USD 35.66–36.73 on volume of 2,292,616 shares. Market capitalization is $8.65B, with a 52-week range of USD 33.72–43.62 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 10:11 UTC.
Also available as compact Markdown for AI agents: nexqual.com/CTRE.md
Key facts (CTRE)
- Analysts: Buy (mean 2.00 on a 1–5 scale) (14 analysts), mean target USD 43.64 (range 41–49).
- Total return with dividends: 1Y +9.1% vs S&P 500 +14.9%; 5Y +118.8% vs S&P 500 +80.3%.
- Next earnings: 2026-11-05, EPS estimate USD 0.43, revenue estimate $159M.
Analysts (CTRE)
Consensus Buy (mean 2.00 on a 1–5 scale), 14 analysts; mean target USD 43.64 (low 41, high 49).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-19 | Wells Fargo | Target lowered | Overweight | $44 → $43 |
| 2026-10-16 | JP Morgan | Initiated | Neutral | $41 |
| 2026-10-13 | UBS | Target lowered | Buy | $48 → $44 |
| 2026-10-05 | Raymond James | Target lowered | Outperform | $45 → $42 |
| 2026-10-05 | RBC Capital | Reiterated | Sector Perform | $43 |
| 2026-10-05 | BMO Capital | Target lowered | Outperform | $47 → $45 |
| 2026-09-01 | Wells Fargo | Target lowered | Overweight | $47 → $44 |
| 2026-08-14 | RBC Capital | Downgrade | Outperform → Sector Perform | $44 → $43 |
| 2026-08-10 | Cantor Fitzgerald | Target raised | Neutral | $42 → $43 |
Total return (dividends reinvested) (CTRE)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | +9.1% | +118.8% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +9.2% | +16.9% |
| Volatility (annualized) | 25.0% | 23.1% |
| Max drawdown | -17.0% (Jul 2026→Oct 2026) | -28.7% (Jan 2022→Apr 2022) |
CTRE analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $0.43 | $0.42 | +0.2% | $159.0M | 5 |
| Next quarter (ends Dec 2026) | $0.44 | $0.43 | +2.3% | $180.3M | 4 |
| Current fiscal year (ends Dec 2026) | $1.72 | $1.80 | -4.9% | $627.5M | 3 |
| Next fiscal year (ends Dec 2027) | $1.88 | $1.74 | +7.7% | $823.7M | 4 |
Key Statistics (as of October 23, 2026 at 10:11 UTC)
| Price | USD 36.62 |
|---|---|
| Change | ▲ 2.72% (up) |
| Previous Close | USD 35.65 |
| Open | USD 35.84 |
| Day Range | USD 35.66 – 36.73 |
| 52-Week Range | USD 33.72 – 43.62 |
| Volume | 2,292,616 shares |
| Market Cap | $8.65B |
| Exchange | NYQ |
Technical Analysis (CTRE)
Nexqual's technical model rates CTRE "NEUTRAL" based on 2 bullish and 3 bearish signals across 127 daily candles, as of October 23, 2026 at 10:11 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 46.95 (neutral) |
| vs SMA50 | Below (USD 37.89) |
| MACD | -0.48 (negative) |
Analyst Ratings (CTRE)
Wall Street analysts rate CTRE "Buy" based on 14 analysts, with a mean price target of USD 43.64 (range USD 41–49), per Nexqual as of October 23, 2026 at 10:11 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 14 |
| Mean Target | USD 43.64 |
| High Target | USD 49 |
| Low Target | USD 41 |
| Buy / Hold / Sell | 12 / 2 / 0 |
Earnings (CTRE)
| Next Earnings Date | 2026-11-05 |
|---|---|
| EPS Estimate | USD 0.43 |
| Revenue Estimate | $158.95M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 0.39 vs est 0.39 ▲ beat |
| 2026-03-31 | USD 0.36 vs est 0.37 ▼ miss |
| 2025-12-31 | USD 0.36 vs est 0.38 ▼ miss |
| 2025-09-30 | USD 0.33 vs est 0.38 ▼ miss |
Source: Nexqual, October 23, 2026 at 10:11 UTC.
Financials & Fundamentals (CTRE)
| Total Revenue | $571.43M |
|---|---|
| Revenue Growth (latest quarter, YoY) | +43.50% |
| Gross Margin | +96.36% |
| Operating Margin | +64.86% |
| Profit Margin | +62.19% |
| ROE | +9.06% |
| Debt / Equity | 0.27 |
| Current Ratio | 3.3 |
| Total Cash | $47.59M |
| Total Debt | $1.21B |
Source: Nexqual, October 23, 2026 at 10:11 UTC.
Financial Health Score (CTRE)
Nexqual rates CareTrust REIT, Inc.'s overall financial health "Solid" across five dimensions, as of October 23, 2026 at 10:11 UTC.
| Growth | Strong — Revenue +61% YoY (annual) |
|---|---|
| Profitability | Strong — Operating margin 65% |
| Balance Sheet | Strong — $48M cash vs $1.21B debt |
| Cash Flow | Solid — Operating cash flow $394M (FY ended Dec 2025, 10-K) |
| Efficiency | Mixed — ROE 9%, ROA 4.4% |
Ownership (CTRE)
| Insider Ownership | +0.78% |
|---|---|
| Institutional Ownership | +108.93% |
| Shares Outstanding | 236.29M |
| Float | 234.38M |
| Short % of Float | +5.54% |
Source: Nexqual, October 23, 2026 at 10:11 UTC.
Leadership (CTRE)
CareTrust REIT, Inc. is led by David Matthew Sedgwick, CEO, President & Director, per Nexqual as of October 23, 2026 at 10:11 UTC.
| CEO, President & Director | David Matthew Sedgwick |
|---|---|
| CFO & Treasurer | Derek Jonathon Bunker |
| Senior Vice President of Corporate Counsel | Joseph D. Layne |
| Senior Vice President of Asset Management | Eric Gillis |
| Senior Vice President of Investments | Tri Tran |
Major Backers & Investors (CTRE)
Notable institutional backers of CareTrust REIT, Inc. include Cohen & Steers Inc., FMR, LLC, T. Rowe Price, according to Nexqual as of October 23, 2026 at 10:11 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Cohen & Steers Inc. | 5.4% |
| FMR, LLC | 4.45% |
| T. Rowe Price | 4.29% |
| Wellington Management | 4.1% |
| Fidelity | 1.1% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 17.24% |
| Vanguard Group | 13.34% |
| State Street | 5.27% |
| Geode Capital | 3.17% |
| Nuveen | 2.13% |
Source: Nexqual, October 23, 2026 at 10:11 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| AHR | American Healthcare REIT, Inc. | USD 53.4 | ▲ 1.02% |
| HR | Healthcare Realty Trust Incorpo | USD 17.93 | ▲ 4% |
| DOC | Healthpeak Properties, Inc. | USD 19.34 | ▲ 4.65% |
| OHI | Omega Healthcare Investors, Inc | USD 46.3 | ▲ 4.16% |
| SBRA | Sabra Health Care REIT, Inc. | USD 19.6 | ▲ 3.7% |
| NHI | National Health Investors, Inc. | USD 66.96 | ▲ 3.14% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 10:11 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt